Guanidinoalkyl glycine .beta.-amino acids useful for inhibiting tumor metastasis
US5681820A · kind A · utility
9Cited by
2References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 16, 1995 |
| Grant date | Oct 28, 1997 |
| Priority date | — |
| Expiry date | May 16, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention herein relates to a method of treating a condition mediated by inhibition of .alpha..sub.v .beta..sub.3 integrins and a method of inhibiting tumor metastasis by administering a therapeutically effective amount of a compound having the following formula ##STR1## or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.